In conclusion, AZD5363, a potent and selective small molecule AKT inhibitor, demonstrates the effectiveness to suppress growth of PI3KCA mutant GC cells in vitro and PDGCX model in vivo. The gene discussed is AKT1; the disease is gastric cancer.